Is Olema Pharmaceuticals, Inc. profitable?

Olema Pharmaceuticals, Inc. is not currently profitable: it reported a net loss of $185.2M over the trailing twelve months.

What is Olema Pharmaceuticals, Inc.'s earnings per share?

Olema Pharmaceuticals, Inc.'s diluted EPS over the trailing twelve months is $-2.03.

Where does Olema Pharmaceuticals, Inc.'s income statement data come from?

Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Olema Pharmaceuticals, Inc. OLMA Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Research and development	$49.23M+60.8%	$43.22M+33.8%	$39.95M+20.2%	$43.9M+50.8%	$30.62M+2.5%
General and administrative	$8.75M+106%	$6.86M+53.6%	$5.93M+34.8%	$3.96M-10.4%	$4.25M-4.6%
Other operating expenses	$57.99M+66.3%	$50.08M+36.2%	$45.88M+21.9%	$47.86M+42.7%	$34.87M+1.6%
Total operating expenses	$57.99M+66.3%	$50.08M+36.2%	$45.88M+21.9%	$47.86M+42.7%	$34.87M+1.6%
Operating income	-$57.99M-66.3%	-$50.08M-36.2%	-$45.88M-21.9%	-$47.86M-42.7%	-$34.87M-1.6%
Interest income	$4.78M+5.6%	$4.01M+21.7%	$3.65M+24.6%	$4.04M+30.1%	$4.52M+35.0%
Other income (expense), net	$4.9M+9.2%	$4.02M+25.7%	$3.66M+19.4%	$4.08M+29.6%	$4.48M+33.1%
Net income	-$53.09M-74.7%	-$46.06M-37.2%	-$42.22M-22.2%	-$43.78M-44.1%	-$30.39M+1.9%
Diluted earnings per share	-$0.52-44.4%	-$0.51-27.5%	-$0.49+18.3%	-$0.51+5.6%	-$0.36+35.7%
Basic earnings per share	-$0.52-44.4%	-$0.51-27.5%	-$0.49+18.3%	-$0.51+5.6%	-$0.36+35.7%
Weighted-average shares, diluted	102.8M+20.3%	87M+48.1%	85.7M+49.7%	85.5M+51.9%	85.4M+53.7%
Weighted-average shares, basic	102.8M+20.3%	87M+48.1%	85.7M+49.7%	85.5M+51.9%	85.4M+53.7%
Other income, net (Note 6)	$121K+403%	$13K—	$12K-91.3%	$38K-5.0%	-$40K-335%
EBIT	-$57.99M-66.3%	-$50.08M-36.2%	-$45.88M-21.9%	-$47.86M-42.7%	-$34.87M-1.6%
EBITDA	-$57.87M-66.5%	-$49.9M-36.1%	-$45.83M-22.1%	-$47.73M-42.8%	-$34.75M-1.4%
EBITDA	-$57.87M-66.5%	-$49.9M-36.1%	-$45.83M-22.1%	-$47.73M-42.8%	-$34.75M-1.4%
EBIT	-$57.99M-66.3%	-$50.08M-36.2%	-$45.88M-21.9%	-$47.86M-42.7%	-$34.87M-1.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is Olema Pharmaceuticals, Inc. profitable?: Olema Pharmaceuticals, Inc. is not currently profitable: it reported a net loss of $185.2M over the trailing twelve months.
What is Olema Pharmaceuticals, Inc.'s earnings per share?: Olema Pharmaceuticals, Inc.'s diluted EPS over the trailing twelve months is $-2.03.
Where does Olema Pharmaceuticals, Inc.'s income statement data come from?: Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.